Get the Stockscreener App
6.46
4.86%
-0.33
Capsovision Inc stock is traded at $6.46, with a volume of 151.84K.
It is down -4.86% in the last 24 hours and up +1.57% over the past month.
CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.
See More
Previous Close:
$6.79
Open:
$6.5
24h Volume:
151.84K
Relative Volume:
1.05
Market Cap:
$322.76M
Revenue:
$13.56M
Net Income/Loss:
$-26.97M
P/E Ratio:
-11.25
EPS:
-0.5742
Net Cash Flow:
$-24.04M
1W Performance:
-9.01%
1M Performance:
+1.57%
6M Performance:
+33.75%
1Y Performance:
+60.70%
1-Day Range:
$6.10
$6.68
1-Week Range:
$6.10
$7.00
52-Week Range:
$3.4341
$15.37
Capsovision Inc Stock (CV) Company Profile
Name
Capsovision Inc
Sector
Industry
Phone
(408) 370-4790
Address
18805 COX AVENUE SUITE 250, SARATOGA
Compare CV vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CV
Capsovision Inc
|
6.46 | 342.75M | 13.56M | -26.97M | -24.04M | -0.5742 |
ABT
Abbott Laboratories
|
111.25 | 191.92B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
339.21 | 133.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
91.27 | 116.18B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
51.83 | 74.52B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
91.60 | 53.63B | 6.30B | 1.07B | 1.09B | 1.8406 |
Capsovision Inc Stock (CV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-28-25 | Initiated | Roth Capital | Buy |
| Jul-28-25 | Initiated | The Benchmark Company | Speculative Buy |
Capsovision Inc Stock (CV) Latest News
CapsoVision stock rating maintained at Speculative Buy by Benchmark - Investing.com
CapsoVision Inc (CV) (Q2 2026) Earnings Call Highlights: AI Launch Drives Growth Amid Pricing ... By GuruFocus - Investing.com Canada
CapsoVision Q2 Earnings Call Highlights - MarketBeat
CapsoVision Reports Q2 2026 Financials: Inventory Growth and Balance Sheet Update - Kalkine Media
CapsoVision Q2 Results: Revenue rises 10% to $3.6 million - scanx.trade
Earnings call transcript: CapsoVision Q2 2026 loss widens as shares fall after hours - Investing.com
CapsoVision Files Mixed Shelf for Up to $250 Million in Securities - marketscreener.com
CapsoVision Q2 2026 Earnings Call Transcript - benzinga.com
CapsoVision Launches $100 Million At-the-Market Equity Program - TipRanks
CapsoVision (CV) widens losses in H1 2026 and flags going concern risk - Stock Titan
CapsoVision, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
CapsoVision, Inc. Provides Revenue Guidance for the Second Half of 2026 - marketscreener.com
CapsoVision Reports Second Quarter 2026 Financial Results - Yahoo Finance
CapsoVision Inc (CV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CapsoVision Inc (CV) Stock News Today - TradingKey
CapsoVision® Announces International Launch of AI Highlights - The Manila Times
CapsoVision launches AI feature for capsule endoscopy abroad - Investing.com
CapsoVision launches AI Highlights internationa... - pluang.com
CV|CapsoVision Inc|Price:6.580|Chg%:-0.120 - tradingkey.com
CapsoVision to Release Second Quarter 2026 Financial Results on August 13, 2026 - GlobeNewswire
CapsoVision Inc. (CV) Q1 2026 Earnings: Wider-Than-Expected Loss Amid Limited DisclosurePretax Income Report - dars.gov.et
CapsoVision (NASDAQ:CV) Major Shareholder Purchases 61,068 Shares of Stock - MarketBeat
CapsoVision Inc (CV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CV|CapsoVision Inc|Price:6.620|Chg%:+0.130 - TradingKey
CapsoVision Inc (CV) Cash Flow - TradingKey
CapsoVision Inc (CV) Balance Sheet - TradingKey
CapsoVision Inc (CV) Income Statement - TradingKey
CapsoVision Inc (CV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CapsoVision Inc (CV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CapsoVision Inc (CV) Valuation: PE, PB & Fair Value Analysis - TradingKey
CV|CapsoVision Inc|Price:6.540|Chg%:+0.050 - TradingKey
CapsoVision Inc (CV) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Form 4 CapsoVision Inc For: 21 July By Investing.com - Investing.com Canada
CapsoVision director Eliyahou Harari buys $410k in company stock - Investing.com
CapsoVision director Eliyahou Harari buys $410k in company stock By Investing.com - Investing.com Nigeria
CapsoVision 10% owner Eliyahou Harari reports purchase of 61,068 common shares for $410,987.64 - Bitget
U.S. Smart Pills Market to Reach US$ 619.10 Million by 2033 as - openPR.com
CapsoVision (CV) AGM 2026 Summary - Quartr
CapsoVision Inc. (CV) Surges 3.81% as Shares Test Key Resistance LevelsPrice Action Signals - dars.gov.et
CapsoVision 10% owner Eliyahou Harari buys $495,117 in stock By Investing.com - Investing.com UK
CapsoVision Inc. (CV) Surges Over 3.8% as Bullish Momentum Builds Toward Key ResistanceRip Sell Trade - dars.gov.et
Form 4 CapsoVision Inc For: 10 July By Investing.com - Investing.com India
CapsoVision 10% owner Eliyahou Harari buys $495,117 in stock - Investing.com
Insider Buyers Lose US$22k As CapsoVision Sheds US$75m - simplywall.st
Form 4 CapsoVision Inc For: 7 July - Investing.com India
CapsoVision 10% owner Eliyahou Harari buys $101,811 in CV stock By Investing.com - Investing.com Australia
CapsoVision 10% owner Eliyahou Harari buys $101,811 in CV stock - Investing.com
Form 4 CapsoVision Inc For: 7 July By Investing.com - Investing.com UK
CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors - The Manila Times
CapsoVision appoints gastroenterologist David Shields to board - Investing.com
CapsoVision adds Shields to board, refines clinical focus - TipRanks
Capsovision Inc Stock (CV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
1.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):